Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshio Sumida

Showing results (201-210 of 220) with videos related to

Pageof 22
Sort By:
Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 4, 2023
Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2014 to 2018 in Japan: A large-scale multicenter retrospective studyHideki Fujii, Yuichiro Suzuki, Koji Sawada, et al.
Alimentary Pharmacology & Therapeutics|April 23, 2024
Hepatic inflammation and fibrosis are profiles related to mid-term mortality in biopsy-proven MASLD: A multicenter study in JapanTsubasa Tsutsumi, Takumi Kawaguchi, Hideki Fujii, et al.
Clinical and Molecular Hepatology|January 24, 2024
Prognosis of biopsy-confirmed metabolic dysfunction- associated steatotic liver disease: A sub-analysis of the CLIONE studyMichihiro Iwaki, Hideki Fujii, Hideki Hayashi, et al.
Gastro Hep Advances|November 19, 2024
Clinical Characteristics of Steatotic Liver Disease Categories in a Large Cohort of Japanese Health Checkup ParticipantsYoshihiro Kamada, Hideki Fujii, Yuichiro Suzuki, et al.
Clinical and Translational Gastroenterology|May 26, 2022
Association of Serum and Fecal Bile Acid Patterns With Liver Fibrosis in Biopsy-Proven Nonalcoholic Fatty Liver Disease: An Observational StudyYuki Kasai, Takaomi Kessoku, Kosuke Tanaka, et al.
Journal of Gastroenterology and Hepatology|February 17, 2023
Noninvasive tests predict liver-related events and mortality in patients with nonalcoholic fatty liver disease: sub-analysis of the CLIONE-Asia studyHiroshi Ishiba, Yoshio Sumida, Yoshihiro Kamada, et al.
Gastro Hep Advances|August 12, 2024
Validation of Noninvasive Markers for HCC Risk Stratification in 1389 Patients With Biopsy-proven NAFLDHidenori Toyoda, Hideki Fujii, Michihiro Iwaki, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 20, 2022
Clinical Outcomes in Biopsy-Proven Nonalcoholic Fatty Liver Disease Patients: A Multicenter Registry-based Cohort StudyHideki Fujii, Michihiro Iwaki, Hideki Hayashi, et al.
Gastro Hep Advances|June 11, 2025
Prediction of Advanced Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease by Type IV Collagen 7SHiroshi Ishiba, Yoshio Sumida, Yoshihiro Kamada, et al.
Journal of Gastroenterology|December 5, 2022
SWOT analysis of noninvasive tests for diagnosing NAFLD with severe fibrosis: an expert review by the JANIT ForumYoshihiro Kamada, Takahiro Nakamura, Satoko Isobe, et al.
Pageof 22

Showing results (201-210 of 220) with videos related to

Sort By:
Pageof 22
Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 4, 2023
Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2014 to 2018 in Japan: A large-scale multicenter retrospective studyHideki Fujii, Yuichiro Suzuki, Koji Sawada, et al.
Alimentary Pharmacology & Therapeutics|April 23, 2024
Hepatic inflammation and fibrosis are profiles related to mid-term mortality in biopsy-proven MASLD: A multicenter study in JapanTsubasa Tsutsumi, Takumi Kawaguchi, Hideki Fujii, et al.
Clinical and Molecular Hepatology|January 24, 2024
Prognosis of biopsy-confirmed metabolic dysfunction- associated steatotic liver disease: A sub-analysis of the CLIONE studyMichihiro Iwaki, Hideki Fujii, Hideki Hayashi, et al.
Gastro Hep Advances|November 19, 2024
Clinical Characteristics of Steatotic Liver Disease Categories in a Large Cohort of Japanese Health Checkup ParticipantsYoshihiro Kamada, Hideki Fujii, Yuichiro Suzuki, et al.
Clinical and Translational Gastroenterology|May 26, 2022
Association of Serum and Fecal Bile Acid Patterns With Liver Fibrosis in Biopsy-Proven Nonalcoholic Fatty Liver Disease: An Observational StudyYuki Kasai, Takaomi Kessoku, Kosuke Tanaka, et al.
Journal of Gastroenterology and Hepatology|February 17, 2023
Noninvasive tests predict liver-related events and mortality in patients with nonalcoholic fatty liver disease: sub-analysis of the CLIONE-Asia studyHiroshi Ishiba, Yoshio Sumida, Yoshihiro Kamada, et al.
Gastro Hep Advances|August 12, 2024
Validation of Noninvasive Markers for HCC Risk Stratification in 1389 Patients With Biopsy-proven NAFLDHidenori Toyoda, Hideki Fujii, Michihiro Iwaki, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 20, 2022
Clinical Outcomes in Biopsy-Proven Nonalcoholic Fatty Liver Disease Patients: A Multicenter Registry-based Cohort StudyHideki Fujii, Michihiro Iwaki, Hideki Hayashi, et al.
Gastro Hep Advances|June 11, 2025
Prediction of Advanced Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease by Type IV Collagen 7SHiroshi Ishiba, Yoshio Sumida, Yoshihiro Kamada, et al.
Journal of Gastroenterology|December 5, 2022
SWOT analysis of noninvasive tests for diagnosing NAFLD with severe fibrosis: an expert review by the JANIT ForumYoshihiro Kamada, Takahiro Nakamura, Satoko Isobe, et al.
Pageof 22